Vyloo

Lactobacillus Rhamnosus 2 5billion Cells medicines online

About Lactobacillus Rhamnosus 2 5billion Cells

Lactobacillus Rhamnosus 2 5billion Cells appears as an active ingredient (salt) in various prescription and OTC medicines. Use this page to browse related products listed on Vyloo and match strength and form to your prescription or prior purchase. Product information is educational for shopping only — it is not medical advice. Upload a valid prescription when the product is marked Rx.

View all results
Nestle Lactogrow Nutritious Milk Drink (3-6 Years) Biscuity and VanillaOTC

Nestle Lactogrow Nutritious Milk Drink (3-6 Years) Biscuity and Vanilla

Nestle India Ltd · box of 400 gm Powder

₹400
Nestle Lactogen Stage 1 Upto 6 Months RefillOTC

Nestle Lactogen Stage 1 Upto 6 Months Refill

Nestle India Ltd · box of 400 gm Powder

₹485
Lee-Biotic Capsule | Pre & Probiotic Supplement | For Gut HealthNon-Rx

Lee-Biotic Capsule | Pre & Probiotic Supplement | For Gut Health

Leeford Healthcare Ltd · 10 strip of 10 capsules

₹125
Biodoxi-LB CapsuleRx

Biodoxi-LB Capsule

Zydus Healthcare Limited · 10.0 capsules in 1 strip

₹103
Bgclav-LB 625 TabletRx

Bgclav-LB 625 Tablet

Kenrox Healthcare Pvt. Ltd · 10.0 tablets in 1 strip

₹239
Cefto LB TabletRx

Cefto LB Tablet

Clamed Healthcare Pvt. Ltd. · 10.0 tablets in 1 strip

₹608
Biozif-LB TabletRx

Biozif-LB Tablet

Noble Bio Life Sciences Pvt Ltd · 10.0 tablets in 1 strip

₹134
Boostim LB 625 TabletRx

Boostim LB 625 Tablet

Maneesh Pharmaceuticals Ltd · 10.0 tablets in 1 strip

₹250
Bid LB 250mg/60mg TabletRx

Bid LB 250mg/60mg Tablet

Merck Ltd · 10.0 tablets in 1 strip

₹17
Cefivir LB 200mg TabletRx

Cefivir LB 200mg Tablet

Viribus Healthcare · 10.0 tablets in 1 strip

₹122
Cifrix LB 200mg Tablet DTRx

Cifrix LB 200mg Tablet DT

Clarix Healthcare · 10.0 tablet dt in 1 strip

₹131
Bludrox LB 250 mg/60 mg TabletRx

Bludrox LB 250 mg/60 mg Tablet

Blue Cross Laboratories Ltd · 10.0 tablets in 1 strip

₹21

Frequently asked questions

All salts · Health conditions · Editorial policy